MRI造影剤の世界市場レポート 2025年

MRI造影剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.1％で21億1,000万米ドルに成長します。予測期間の成長は、がん患者の増加、慢性疾患の有病率の増加、研究開発投資と活動の増加、ヘルスケア支出の増加、MRIアプリケーションの拡大に起因します。予測期間の主な動向としては、共同研究の進展、技術の進歩、製品革新、より安全で効果的な造影剤の開発、製薬会社やバイオテクノロジー企業による製品革新などが挙げられます。

がん患者の増加が予想され、MRI造影剤市場の成長を牽引するとみられます。がん患者の増加は、人口動態の変化、ライフスタイルの選択、環境の影響、遺伝的素因、ヘルスケアの進歩など、多くの要因に起因しています。MRI検査では、ガドリニウムベースの化合物を含む造影剤を利用して、組織の磁気特性を変化させることで可視化を強化し、腫瘍の検出、サイズ決定、特徴付けを支援するとともに、周辺組織への浸潤を評価します。例えば、世界保健機関（WHO）が2024年2月に発表した報告書によると、2022年の世界の推定新規がん患者数は2,000万人に急増し、970万人が死亡しました。予測によれば、2050年までにがん罹患者数は大幅に増加し、2022年の推定罹患者数2,000万人に対し、77％増の3,500万人以上になると予想されています。したがって、がんの発生率の高まりは、MRI造影剤市場拡大の原動力となっています。

MRI造影剤市場の主要企業は、大環状ガドリニウム系造影剤（GBCA）などの先端製品の開発・販売に戦略的に注力しており、MRI画像診断の診断能力と安全性プロファイルを強化しています。大環状ガドリニウム系造影剤（GBCA）は、医療用イメージング、特に磁気共鳴画像法（MRI）で利用される造影剤のカテゴリーを代表します。例えば、2023年2月、フランスを拠点とするMRI造影剤のプロバイダーであるGuerbet社は、Elucirem（ガドピクレノール）注射剤を発表しました。Elucirem（ガドピクレノール）注射剤は、安定性の高い大環状ガドリニウム系造影剤（GBCA）であることが特徴で、MRIにおいてクラス最高の弛緩性を誇る。この革新的なガドピクレノール製剤は、中枢神経系および身体の様々な領域において、異常な血管を有する病変の検出および可視化に卓越した効果を示します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界MRI造影剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のMRI造影剤市場：成長率分析
• 世界のMRI造影剤市場の実績：規模と成長, 2019-2024
• 世界のMRI造影剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界MRI造影剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のMRI造影剤市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞外造影剤
• 血のプールエージェント
• 肝胆道系薬剤
• 世界のMRI造影剤市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 神経疾患
• 筋骨格障害
• 心血管疾患
• がん検出
• その他の用途
• 世界のMRI造影剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断および画像診断センター
• 調査機関
• その他のエンドユーザー
• 世界のMRI造影剤市場細胞外造影剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ガドリニウム造影剤（GBCA）
• ガドリニウム以外の造影剤
• 世界のMRI造影剤市場、血液プールエージェントのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高分子薬剤
• ナノ粒子ベースの薬剤
• 世界のMRI造影剤市場肝胆道系薬剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肝細胞特異的薬剤
• 胆汁特異性薬剤

第7章 地域別・国別分析

• 世界のMRI造影剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のMRI造影剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• MRI造影剤市場：競合情勢
• MRI造影剤市場：企業プロファイル
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
  • JB Chemicals and Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Jiangsu Hengrui Pharmaceutical Co. Ltd.
• Bracco S.p.A.
• Miltenyi Biotec B.V. & Co. KG
• Lantheus Medical Imaging Inc.
• Guerbet LLC
• Curium Pharma
• Spago Nanomedical AB
• AMAG Pharmaceuticals Inc.
• Nanopet Pharma GmbH
• Trivitron Healthcare
• Beijing Beilu Pharmaceuticals Company Limited
• Unijules Life Sciences Ltd.
• Taejoon Pharm Co. Ltd.
• Mediso USA LLC
• Nano Therapeutics Pvt. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• MRI造影剤市場2029：新たな機会を提供する国
• MRI造影剤市場2029：新たな機会を提供するセグメント
• MRI造影剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

MRI contrast media refers to substances utilized in magnetic resonance imaging (MRI) to heighten the visibility of internal body structures. These contrast agents function by modifying the magnetic properties of tissues, thereby enhancing the contrast in resultant images.

The primary MRI contrast media products include extracellular contrast agents, blood-pool agents, and hepatobiliary agents. Extracellular contrast agents are employed in MRI to augment the visibility of internal body structures. They find application in diagnosing various conditions such as neurological disorders, musculoskeletal disorders, cardiovascular disorders, cancer detection, and more. These products are utilized by a range of end-users including hospitals, diagnostic and imaging centers, research institutes, and others.

The MRI contrast media market research report is one of a series of new reports from The Business Research Company that provides MRI contrast media market statistics, including MRI contrast media industry global market size, regional shares, competitors with an MRI contrast media market share, detailed MRI contrast media market segments, market trends, and opportunities, and any further data you may need to thrive in the MRI contrast media industry. This MRI contrast media market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mri contrast media market size has grown strongly in recent years. It will grow from $1.56 billion in 2024 to $1.66 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising demand for early diagnosis, increasing demand for diagnostic accuracy and patient outcomes, increased public awareness, development of combination imaging modalities, identification of novel use cases for contrast agents.

The mri contrast media market size is expected to see strong growth in the next few years. It will grow to $2.11 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rise in cancer cases, growing prevalence of chronic diseases, increasing research and development investment and activities, increasing healthcare expenditure, expanding applications of MRI. Major trends in the forecast period include advancement with collaborative research, technological advancements, product innovation, development of safer and more effective contrast agents, product innovations by pharmaceutical and biotechnology companies.

The anticipated increase in cancer cases is expected to drive growth within the MRI contrast media market. This rise in cancer cases is attributed to a multitude of factors, including demographic shifts, lifestyle choices, environmental influences, genetic predispositions, and advancements in healthcare practices. MRI scans utilize contrast agents containing gadolinium-based compounds to enhance visualization by modifying tissue magnetic properties, aiding in the detection, sizing, and characterization of tumors, as well as evaluating their invasion into surrounding tissues. For instance, a report published by the World Health Organization (WHO) in February 2024 revealed that the global estimated number of new cancer cases surged to 20 million in 2022, resulting in 9.7 million deaths. Projections indicate a substantial increase in cancer cases by 2050, with an anticipated 77% rise to over 35 million new cases, compared to the estimated 20 million cases in 2022. Hence, the mounting incidence of cancer serves as a driving force behind the expansion of the MRI contrast media market.

Key players in the MRI contrast media market are strategically focused on developing and distributing advanced products, such as macrocyclic gadolinium-based contrast agents (GBCA), to augment the diagnostic capabilities and safety profile of MRI imaging procedures. Macrocyclic gadolinium-based contrast agents (GBCA) represent a category of contrast agents utilized in medical imaging, particularly in magnetic resonance imaging (MRI). For instance, in February 2023, Guerbet, a France-based provider of MRI contrast media, unveiled the Elucirem (gadopiclenol) injection. Distinguished by its highly stable macrocyclic gadolinium-based contrast agent (GBCA), Elucirem (gadopiclenol) injection boasts the highest relaxivity in its class for MRI. This innovative formulation of gadopiclenol demonstrates exceptional efficacy in detecting and visualizing lesions with abnormal vascularity across various regions of the central nervous system and the body.

In March 2023, Bracco Imaging S.p.A., an Italy-based healthcare company, concluded the acquisition of the remaining 49% stake in Bracco-Eisai Co. Ltd. for an undisclosed sum. This strategic move is aimed at facilitating swift and adaptable responses to the evolving healthcare industry landscape, with a focus on achieving sustainable contributions to patient care through product utilization. Bracco-Eisai Co. Ltd., based in Japan, is recognized for its provision of MRI contrast media, contributing to Bracco Imaging S.p.A.'s comprehensive portfolio of healthcare solutions.

Major companies operating in the MRI contrast media market are Bayer AG, GE Healthcare Technologies Inc., Fresenius Kabi AG, Fujifilm Holdings Corporation, JB Chemicals and Pharmaceuticals Ltd., Jiangsu Hengrui Pharmaceutical Co. Ltd., Bracco S.p.A., Miltenyi Biotec B.V. & Co. KG, Lantheus Medical Imaging Inc., Guerbet LLC, Curium Pharma, Spago Nanomedical AB, AMAG Pharmaceuticals Inc., Nanopet Pharma GmbH, Trivitron Healthcare, Beijing Beilu Pharmaceuticals Company Limited, Unijules Life Sciences Ltd., Taejoon Pharm Co. Ltd., Mediso USA LLC, Nano Therapeutics Pvt. Ltd., Livealth Biopharma Pvt Ltd., BioPAL Inc., Vitalquan LLC, Shubhra Biotech Pvt Ltd., Rege Imaging & Cine Films Private Limited, Polarean Inc.

North America was the largest region in the MRI contrast media market in 2024. The regions covered in the mri contrast media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mri contrast media market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The MRI contrast media market consists of sales of gadopentetate dimeglumine (Gd-DTPA), gadodiamide, diatrizoate, and gadoversetamide. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

MRI Contrast Media Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mri contrast media market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mri contrast media ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mri contrast media market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Extracellular Contrast Agents; Blood-Pool Agent; Hepatobiliary Agents
• 2) By Application: Neurological Disorders; Musculoskeletal Disorders; Cardiovascular Disorders; Cancer Detection; Other Applications
• 3) By End-User: Hospitals; Diagnostic And Imaging Centers; Research Institutes; Other End Users
• Subsegments:
• 1) By Extracellular Contrast Agents: Gadolinium-Based Contrast Agents (GBCA); Non-Gadolinium-Based Contrast Agents
• 2) By Blood-Pool Agent: Macromolecular Agents; Nanoparticle-Based Agents
• 3) By Hepatobiliary Agents: Hepatocyte-Specific Agents; Biliary-Specific Agents
• Companies Mentioned: Bayer AG; GE Healthcare Technologies Inc.; Fresenius Kabi AG; Fujifilm Holdings Corporation; JB Chemicals and Pharmaceuticals Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. MRI Contrast Media Market Characteristics

3. MRI Contrast Media Market Trends And Strategies

4. MRI Contrast Media Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global MRI Contrast Media Growth Analysis And Strategic Analysis Framework

• 5.1. Global MRI Contrast Media PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global MRI Contrast Media Market Growth Rate Analysis
• 5.4. Global MRI Contrast Media Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global MRI Contrast Media Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global MRI Contrast Media Total Addressable Market (TAM)

6. MRI Contrast Media Market Segmentation

• 6.1. Global MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Extracellular Contrast Agents
• Blood-Pool Agent
• Hepatobiliary Agents
• 6.2. Global MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neurological Disorders
• Musculoskeletal Disorders
• Cardiovascular Disorders
• Cancer Detection
• Other Applications
• 6.3. Global MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic And Imaging Centers
• Research Institutes
• Other End Users
• 6.4. Global MRI Contrast Media Market, Sub-Segmentation Of Extracellular Contrast Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gadolinium-Based Contrast Agents (GBCA)
• Non-Gadolinium-Based Contrast Agents
• 6.5. Global MRI Contrast Media Market, Sub-Segmentation Of Blood-Pool Agent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Macromolecular Agents
• Nanoparticle-Based Agents
• 6.6. Global MRI Contrast Media Market, Sub-Segmentation Of Hepatobiliary Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hepatocyte-Specific Agents
• Biliary-Specific Agents

7. MRI Contrast Media Market Regional And Country Analysis

• 7.1. Global MRI Contrast Media Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global MRI Contrast Media Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific MRI Contrast Media Market

• 8.1. Asia-Pacific MRI Contrast Media Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China MRI Contrast Media Market

• 9.1. China MRI Contrast Media Market Overview
• 9.2. China MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India MRI Contrast Media Market

• 10.1. India MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan MRI Contrast Media Market

• 11.1. Japan MRI Contrast Media Market Overview
• 11.2. Japan MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia MRI Contrast Media Market

• 12.1. Australia MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia MRI Contrast Media Market

• 13.1. Indonesia MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea MRI Contrast Media Market

• 14.1. South Korea MRI Contrast Media Market Overview
• 14.2. South Korea MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe MRI Contrast Media Market

• 15.1. Western Europe MRI Contrast Media Market Overview
• 15.2. Western Europe MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK MRI Contrast Media Market

• 16.1. UK MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany MRI Contrast Media Market

• 17.1. Germany MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France MRI Contrast Media Market

• 18.1. France MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy MRI Contrast Media Market

• 19.1. Italy MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain MRI Contrast Media Market

• 20.1. Spain MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe MRI Contrast Media Market

• 21.1. Eastern Europe MRI Contrast Media Market Overview
• 21.2. Eastern Europe MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia MRI Contrast Media Market

• 22.1. Russia MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America MRI Contrast Media Market

• 23.1. North America MRI Contrast Media Market Overview
• 23.2. North America MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA MRI Contrast Media Market

• 24.1. USA MRI Contrast Media Market Overview
• 24.2. USA MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada MRI Contrast Media Market

• 25.1. Canada MRI Contrast Media Market Overview
• 25.2. Canada MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America MRI Contrast Media Market

• 26.1. South America MRI Contrast Media Market Overview
• 26.2. South America MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil MRI Contrast Media Market

• 27.1. Brazil MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East MRI Contrast Media Market

• 28.1. Middle East MRI Contrast Media Market Overview
• 28.2. Middle East MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa MRI Contrast Media Market

• 29.1. Africa MRI Contrast Media Market Overview
• 29.2. Africa MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. MRI Contrast Media Market Competitive Landscape And Company Profiles

• 30.1. MRI Contrast Media Market Competitive Landscape
• 30.2. MRI Contrast Media Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. JB Chemicals and Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. MRI Contrast Media Market Other Major And Innovative Companies

• 31.1. Jiangsu Hengrui Pharmaceutical Co. Ltd.
• 31.2. Bracco S.p.A.
• 31.3. Miltenyi Biotec B.V. & Co. KG
• 31.4. Lantheus Medical Imaging Inc.
• 31.5. Guerbet LLC
• 31.6. Curium Pharma
• 31.7. Spago Nanomedical AB
• 31.8. AMAG Pharmaceuticals Inc.
• 31.9. Nanopet Pharma GmbH
• 31.10. Trivitron Healthcare
• 31.11. Beijing Beilu Pharmaceuticals Company Limited
• 31.12. Unijules Life Sciences Ltd.
• 31.13. Taejoon Pharm Co. Ltd.
• 31.14. Mediso USA LLC
• 31.15. Nano Therapeutics Pvt. Ltd.

32. Global MRI Contrast Media Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The MRI Contrast Media Market

34. Recent Developments In The MRI Contrast Media Market

35. MRI Contrast Media Market High Potential Countries, Segments and Strategies

• 35.1 MRI Contrast Media Market In 2029 - Countries Offering Most New Opportunities
• 35.2 MRI Contrast Media Market In 2029 - Segments Offering Most New Opportunities
• 35.3 MRI Contrast Media Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer